Related Experiment Video
Updated: Sep 13, 2025
Widespread Transduction of Mouse Neocortical Neurons by Subarachnoid Injection of AAV2
Published on: May 23, 2025
AAV vectors for specific and efficient gene expression in microglia
Ryo Aoki1, Ayumu Konno2, Nobutake Hosoi1
1Department of Neurophysiology & Neural Repair, Gunma University Graduate School of Medicine, Maebashi, Gunma 371-8511, Japan.
Abstract:
Microglia are crucial targets for therapeutic interventions in diseases like Alzheimer's and stroke, but efficient gene delivery to these immune cells is challenging. We developed an adeno-associated virus (AAV) vector that achieves specific and efficient gene delivery to microglia. This vector incorporates the mIba1 promoter, GFP, miRNA target sequences (miR.Ts), WPRE, and poly(A) signal. Positioning miR.Ts on both sides of WPRE significantly suppressed non-microglial expression, achieving over 90% specificity and more than 60% efficiency in microglia-specific gene expression 3 weeks post-administration. Additionally, this vector enabled GCaMP expression, facilitating real-time calcium dynamics monitoring in microglial processes. Using a blood-brain barrier-penetrant AAV-9P31 capsid variant, intravenous administration resulted in broad and selective microglial GFP expression across the brain. These results establish our AAV vector as a versatile tool for long-term, highly specific, and efficient gene expression in microglia, advancing microglial research and potential therapeutic applications.
Insights
Researchers developed a novel adeno-associated virus (AAV) vector for precise gene delivery to microglia. This tool enhances microglial research and potential therapies for neurological diseases.
Area of Science:
- Neuroscience
- Molecular Biology
- Gene Therapy
Background:
- Microglia are key players in neurological diseases like Alzheimer's and stroke.
- Efficient and specific gene delivery to microglia remains a significant challenge.
- Targeting microglia is crucial for developing new therapeutic strategies.
Purpose of the Study:
- To engineer an adeno-associated virus (AAV) vector for highly specific and efficient microglial gene delivery.
- To validate the vector's performance in terms of specificity, efficiency, and long-term expression.
- To demonstrate the vector's utility for monitoring microglial activity in real-time.
Main Methods:
- Development of a custom AAV vector utilizing the mIba1 promoter, GFP reporter, miRNA target sequences (miR.Ts), WPRE, and poly(A) signal.
- Strategic placement of miR.Ts to minimize off-target expression.
- Administration of the AAV vector, including a blood-brain barrier-penetrant AAV-9P31 capsid variant, via intravenous injection.
Main Results:
- Achieved over 90% specificity and >60% efficiency for microglia-specific gene expression 3 weeks post-administration.
- Demonstrated suppression of non-microglial expression by positioning miR.Ts flanking the WPRE.
- Enabled GCaMP expression for real-time monitoring of microglial calcium dynamics.
- Intravenous administration of the AAV-9P31 variant resulted in widespread, selective microglial expression across the brain.
Conclusions:
- The developed AAV vector provides a versatile tool for achieving long-term, highly specific, and efficient gene expression in microglia.
- This technology significantly advances the potential for microglial research and therapeutic applications in neurological disorders.
- The vector enables precise genetic manipulation and functional studies of microglia in vivo.
